Grove Collaborative (GROV) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Achieved first sequential revenue growth since early 2022 in Q4 2024, marking a pivotal turnaround after 10 quarters of decline.
Delivered positive adjusted EBITDA for full year 2024, with three consecutive quarters of positive operating cash flow.
Voluntarily repaid $72 million in term debt, leaving only $7.5 million in asset-based loans and significantly improving the balance sheet.
Completed acquisitions of Grab Green and 8Greens in Q1 2025, expanding into wellness and sustainable product offerings.
Updated brand focus and tagline to prioritize both human and environmental health.
Financial highlights
Q4 2024 revenue was $49.5 million, up 2.5% sequentially but down 17.4% year-over-year.
Gross margin in Q4 2024 was 52.4%, down from Q3 but up to 53.8% for the full year.
Adjusted EBITDA for Q4 2024 was −$1.6 million (−3.3% margin); full year 2024 Adjusted EBITDA was $1.3 million (0.6% margin).
Operating cash flow was positive for three consecutive quarters in 2024.
Ended Q4 2024 with $24.3 million in cash and $19.4 million in inventory, with a $31 million cash reduction mainly from debt repayment.
Outlook and guidance
Q1 2025 expected to be the lowest revenue quarter due to seasonality and Shopify transition, with improvement through Q2 and Q3.
Revenue projected to improve through Q2 and Q3, with low single-digit year-over-year growth in Q4 2025.
Full-year 2025 revenue expected to be flat to down mid-single digits year-over-year; adjusted EBITDA expected to be break-even to low single-digit millions.
Guidance includes contributions from Grab Green and 8Greens acquisitions.
Brick-and-mortar business to be fully wound down by mid-2025, expected to strengthen the bottom line.
Latest events from Grove Collaborative
- Positive adjusted EBITDA and margin gains offset a 16.8%–17% revenue decline in Q1 2026.GROV
Q1 20268 May 2026 - Shareholders will vote virtually on director elections and auditor ratification for 2026.GROV
Proxy filing28 Apr 2026 - Director elections, auditor ratification, and ESG oversight highlight this year's proxy agenda.GROV
Proxy filing28 Apr 2026 - Positive adjusted EBITDA and margin gains in Q4; 2026 targets breakeven EBITDA and revenue growth.GROV
Q4 20255 Mar 2026 - Q2 2024 saw positive Adjusted EBITDA, improved margins, and a $42M debt paydown amid revenue decline.GROV
Q2 20241 Feb 2026 - Break-even EBITDA, narrowed loss, and positive cash flow as focus shifts to DTC and debt reduction.GROV
Q3 202414 Jan 2026 - Up to 7.76M shares registered for resale by a major investor; no proceeds to the company.GROV
Registration Filing16 Dec 2025 - Shareholders will vote on director elections and auditor ratification at the 2025 annual meeting.GROV
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and major governance updates highlight this year's proxy.GROV
Proxy Filing2 Dec 2025